Aldeyra Therapeutics hits primary end point in 1 of 2 phase 3 trials for reproxalap

In a new National Institutes of Health-funded study led by scientists at the Wilmer Eye Institute, Johns Hopkins Medicine researchers say they have determined that low blood sugar, or hypoglycemia, may promote a breakdown of the blood-retinal barrier.